Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised mice

Virology

Volumn 200, Issue 2, 1994, Pages 547-557

  Tindle, Robert W ^a   Herd, Karen ^a   Londoño, Patricia ^b   Fernando, Germain J P ^a   Chatfield, Steven N ^b   Malcolm, Karen ^a   Dougan, Gordon ^b  

^a ALEXANDRA HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0028296205     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1994.1217     Document Type: Article

References (32)

1. AROGS, P., and FULLER, S. D. (1988). A model for the Flepatitis B core protein: Prediction of antigenic sites and relationship to RNA virus capsid proteins. EMBOJ. 7, 819-824.
2. BROWN, A. L., FRANCIS, M. J., FIASTINGS, G. Z., PARRY, N. R., BARNETT, P. V., ROWLANDS, D. J., and CLARKE, B. E. (1991), Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and confirmationally restricted. Vaccine 9, 595-601.
3. CHATFIELD, S. N., CHARLES, I. G., MAKEOFF, A. J., OXER, M. D., DOU-GAN, D., PICKARD, D., SLATER, D., and FAIRWEATHER, N. F. (1992). Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Biotechnology 10, 888-892.
4. CHEN, L., THOMAS, E. R., Flu, S-L., HELLSTROM, I., and HELLSTROM, K. E. (1991). Human papillomavirus type 16 nucleoprotein E7 is a tumour rejection antigen. Proc. Natl. Acad. Sci. USA 88, 110-114.
5. CLARKE, B. E., BROWN, B. L., GRACE, K. G., HASTINGS, G. E., BROWN, G., ROWLANDS, D. J., and FRANCIS, M. J. (1990). Presentation and immunogenicity of viral epitopes on the surface of hybrid hepatitis B virus core particles produced in bacteria. J. Gen. Virol. 71, 1109-1117.
6. CLARKE, B. E., NEWTON, S. E., CARROLL, A. R., FRANCIS, M. J., APPLEYARD, G., SYNED, A. D., HIGHFIELD, P., ROWLANDS, D. J., and BROWN, F. (1987). Improved immunogenicity of a peptide epitope after fusion to hepatitis B viral core protein. Nature 330, 381-384.
7. COOPER, P. D., TURNER, R., and MCGOVERN, J. (1991).Algammulin (gamma inulin/alum hybrid adjuvant) has greater adjuvanticity than alum for hepatitis B surface antigen in mice. Immunol. Lett. 27, 131-134.
8. DE VILLIERS, E-M., HIRSCH-BEHNAM, A., KNEBEL-DOEBERITZ, C. P., NEUMANN, C., and ZUR FIAUSEN, H. (1989). Two newly identified papillomavirus types (HPV 40 and 57) isolated from mucosal lesions. Virology 171, 248-253.
9. DOTSIKA, E. W., and SANDERSON, C. J. (1987).Interleukin 3 production as a sensitive measure of T-lymphocyte activation in the mouse. Immunology 62, 665-668.
10. FRANCIS, M. J., HASTINGS, G. Z., BROWN, A. L., GRACE, K. G., ROWLANDS, D. J., BROWN, F., and CLARKE, B. E. (1990). Immunological properties of hepatitis B core antigen fusion proteins, Proc. Natl. Acad. Sci. USA 87, 2542-2549.
11. FRAZER, I. H., and TINDLE, R. W. (1992). Cell mediated immunity to papillomaviruses. Papillomavirus Reports 32, 53-58.
12. GILLIS, S., FERM, M. M., OU, W., and Smith, K. A. (1978). Tcell growth factors: parameters of production and a quantitative microassay for activity. J. Immunol. 120, 2027-2032.
13. GRIEP, A. E., HERBER, J., JEON, S., LOHSE, J. K., DUBIELZIG, R. R., and LAMBERT, P. F. (1993). Tumorigenicity by human papillomavirus Type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell tumour growth and differentiation. J. Virol. 67, 1373-1384.
14. HAWLEY-NELSON, P., VOUSDEN, K. H., HUBBERT, N. L, LOWRY, D. R., and SCHILLER, J. T. (1989). HPV 16 E6 and E7 proteins cooperate to immortalise human foreskin keratinocytes. EMBO J. 8, 3905-3910.
15. HOOFNAGLE, J. H., GERETY, R. J., and Barker, L. F, (1973). Antibodies to hepatitis B core particles in man. Lancet 2, 869-873.
16. Hu-Li, J., OHARA, J., WATSON, W., TSANG, W., and PAUL, W. E, (1989). Derivation of a T cell line that is highly responsive to IL-4 and IL (CT-4R) and of an IL-2 hyporesponsive mutant of that line (CT-4S). J. Immunol. 142, 800-807.
17. JOCHMU-SKUDIELKA, I., SCHNEIDER, A., BRAUN, R., KIMMIG, R., SCHNE-WEISS, K. E., SEEDORF, K., and GISSMANN, L. (1989). Antibodies against the human papillomavirus type 1 6 early proteins in human sera: Correlation of anti-E7 activity with cervical cancer. J. Natl. Cancer Inst 87, 1698-1704.
18. KNISKERN, P. J., HAGOPIAN, A., MONTGOMERY, D., DREESMAN, G. R. P., NOTVALL, L., and SUMMERS, M. D. (1986).Unusually high level of expression of a foreign gene (hepatitis B core antigen) in Sacchar-omycescerevisiae. Mol. Cell Biol. 6, 1393-1398.
19. LABEIT, D., BACK, W., WEIZSACKER, F. V., HERMANN, P., MELCHERT, F., LEONARD, K., and LABEIT, S. (1992). Increased detection of HPV 16 virus in invasive, but not in early cervical cancers, J. Med. Virol. 36, 131-135.
20. LANFORD, R. E., LUCKOW, V., KENNEDY, R. C., DREESMANN, G. R., NOTVALL, L, and SUMMERS, M. D. (1989). Expression and characterisation of hepatitis B virus surface antigen polypeptides in insect cells with a baculovirus expression system. J. Virol. 63, 1549-1557.
21. MATOASHEWSKI, G., SCHNEIDER, J., BANKS, L., JONES, N., MURRAY, A., and CRAWFORD, L. (1989). Human papillomavirus 16 DNA cooperates with activated ras in transforming primary cells. EMBO J. 6, 1741-1746.
22. MILICH, D. R., MCLACHLAN, A., MORIARTY, A., and THORNTON, G. (1987). Immune response to hepatitis B virus core antigen (HBcAg): Localisation of T cell recognition sites within HBsAg/ HBeAg. J. Immunol. 139, 1223-1231.
23. PARK, D. S., SELVEY, L. A., KELSALL, S. R., and FRAZER, I. H. (1994), Human papillomavirus type 16 E6, E7 and L1 and type 18 E7proteins produced by recombinant baculoviruses. J. Virol. Methods, in press.
24. PFISTER, H. (1984). Biology and biochemistry of papillomaviruses.Rev. Physiol. Biochem, Pharmacol. 99, 111-181.
25. ROOSSINCK, M. T., JAMEEL, S., LONKIN, S. H., and SIDDIQUI, A. (1986). Expression of hepatitis B viral core region in mammalian cells. Mol. Cell Biol. 6, 1393-1400.
26. RUDLINGER, R., SMITH, I. W., BUNNEY, M. H., and HUNTER, J. A. (1986). Human papillomavirus infections in a group of renal transplant recipients. Br. J. Dermatol. 115, 681-692.
27. STAHL, S., MACKAY, P., MAGAZIN, M., BRUCE, S. A., and MURRAY, K. (1982). Hepatitis B core antigen: Synthesis in E. coli and applications in diagnosis. Proc. Natl. Acad. Set. USA 79, 1606-1610.
28. SMOTKIN, D., and WETTSTEIN, F. O. (1987). The major human papillomavirus protein in cervical cancers in a cytoplasmic phosphopro-tein. J. Virol. 61, 1686-1689.
29. TINDLE, R. W., FERNANDO, G. J. P., STERLING, J. C., and FRAZER, L H. (1991). A “public” T-helper epitope of the E7 transforming protein of human papiliomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes. Proc. Natl. Acad. Sci. USA 88, 5887-5891.
30. TINDLE, R. W., and FRAZER, I. H. (1994).Human pathogenic papillomaviruses.Curt Topics Microbiol. Immunol. 186, 217-252.
31. TINDLE, R. W., SMITH, J. A., GEYSEN, H. M., SELVEY, L. A., and FRAZER, I. H. (1990).Identification of B-epitopes in human papillomavirus (HPV) 16 E7 open reading frame (ORF) protein. J. Gen. Virol, 71, 1347-1354.
32. YASUMOTO, S., BURKHARD, A., DONIGER, J., and Di Paolo, J. A. (1986). Human papillomavirus type 16 DNA-induced malignant transformation of NIH-3T3 cells. J. Virol. 57, 572-577.